Original Article<\/a><\/p>\n[contf]
\n[contfnew]
\n ![](\"http:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/imagesqtbnANd9GcRMd3Tz2gX9xSa6CJyaOj2dokBVcrdaT4yY3R3RI7YmL18vCLZZ-53.jpg\"\/)
<\/p>\n
Politico<\/h5>\n
[contfnewc]
\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"
The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff.<\/p>\n
As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light.<\/p>\n
The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready.<\/p>\n
An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO.<\/p>\n
\u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d<\/p>\n
Delivering on promises and expectations
\nAmsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there.<\/p>\n
\u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d<\/p>\n
Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018<\/p>\n
The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready.<\/p>\n
\u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA.<\/p>\n
The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019.<\/p>\n
The European Medicines Agency building in Canary Wharf | Neil Hall\/EFE<\/p>\n
What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need.<\/p>\n
Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One.<\/p>\n
And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs.<\/p>\n
Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam.<\/p>\n
One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting.<\/p>\n
\u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d<\/p>\n
Winning strategy becomes Achilles\u2019 heel
\nConstructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said.<\/p>\n
For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20.<\/p>\n
The agency needs a minimum 850 workspaces and 15 internal meeting rooms.<\/p>\n
Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting.<\/p>\n
And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said.<\/p>\n
\u201c..<\/p>\n","protected":false},"author":1,"featured_media":28398,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-28397","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"yoast_head":"\n
After Amsterdam high, EU drugs regulator feels the pain - Business News Report<\/title>\n<meta name=\"description\" content=\"The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff. As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light. The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready. An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO. \u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d Delivering on promises and expectations Amsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there. \u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018 The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready. \u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA. The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019. The European Medicines Agency building in Canary Wharf | Neil Hall\/EFE What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need. Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One. And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs. Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam. One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting. \u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d Winning strategy becomes Achilles\u2019 heel Constructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said. For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20. The agency needs a minimum 850 workspaces and 15 internal meeting rooms. Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting. And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said. \u201c..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"After Amsterdam high, EU drugs regulator feels the pain - Business News Report\" \/>\n<meta property=\"og:description\" content=\"The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff. As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light. The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready. An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO. \u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d Delivering on promises and expectations Amsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there. \u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018 The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready. \u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA. The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019. The European Medicines Agency building in Canary Wharf | Neil Hall\/EFE What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need. Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One. And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs. Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam. One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting. \u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d Winning strategy becomes Achilles\u2019 heel Constructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said. For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20. The agency needs a minimum 850 workspaces and 15 internal meeting rooms. Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting. And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said. \u201c..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-08T06:33:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-12-08T06:33:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909680.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"4961\" \/>\n\t<meta property=\"og:image:height\" content=\"3311\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"After Amsterdam high, EU drugs regulator feels the pain\",\"datePublished\":\"2017-12-08T06:33:25+00:00\",\"dateModified\":\"2017-12-08T06:33:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/\"},\"wordCount\":1229,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/h_53909680.jpg\",\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/\",\"name\":\"After Amsterdam high, EU drugs regulator feels the pain - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/h_53909680.jpg\",\"datePublished\":\"2017-12-08T06:33:25+00:00\",\"dateModified\":\"2017-12-08T06:33:33+00:00\",\"description\":\"The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff. As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light. The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready. An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO. \u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d Delivering on promises and expectations Amsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there. \u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018 The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready. \u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA. The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019. The European Medicines Agency building in Canary Wharf | Neil Hall\\\/EFE What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need. Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One. And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs. Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam. One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting. \u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d Winning strategy becomes Achilles\u2019 heel Constructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said. For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20. The agency needs a minimum 850 workspaces and 15 internal meeting rooms. Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting. And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said. \u201c..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/h_53909680.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/h_53909680.jpg\",\"width\":4961,\"height\":3311},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"After Amsterdam high, EU drugs regulator feels the pain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics & Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"After Amsterdam high, EU drugs regulator feels the pain - Business News Report","description":"The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff. As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light. The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready. An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO. \u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d Delivering on promises and expectations Amsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there. \u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018 The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready. \u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA. The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019. The European Medicines Agency building in Canary Wharf | Neil Hall\/EFE What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need. Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One. And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs. Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam. One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting. \u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d Winning strategy becomes Achilles\u2019 heel Constructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said. For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20. The agency needs a minimum 850 workspaces and 15 internal meeting rooms. Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting. And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said. \u201c..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/","og_locale":"en_US","og_type":"article","og_title":"After Amsterdam high, EU drugs regulator feels the pain - Business News Report","og_description":"The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff. As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light. The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready. An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO. \u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d Delivering on promises and expectations Amsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there. \u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018 The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready. \u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA. The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019. The European Medicines Agency building in Canary Wharf | Neil Hall\/EFE What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need. Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One. And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs. Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam. One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting. \u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d Winning strategy becomes Achilles\u2019 heel Constructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said. For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20. The agency needs a minimum 850 workspaces and 15 internal meeting rooms. Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting. And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said. \u201c..","og_url":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2017-12-08T06:33:25+00:00","article_modified_time":"2017-12-08T06:33:33+00:00","og_image":[{"width":4961,"height":3311,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909680.jpg","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"After Amsterdam high, EU drugs regulator feels the pain","datePublished":"2017-12-08T06:33:25+00:00","dateModified":"2017-12-08T06:33:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/"},"wordCount":1229,"commentCount":0,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909680.jpg","articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/","url":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/","name":"After Amsterdam high, EU drugs regulator feels the pain - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909680.jpg","datePublished":"2017-12-08T06:33:25+00:00","dateModified":"2017-12-08T06:33:33+00:00","description":"The European Medicines Agency\u2019s move to Amsterdam after Brexit was supposed to make for smooth sailing and a happy 900-member staff. As the afterglow of winning the contest to host the EU\u2019s drug regulator subsides, some unpleasant realities of the shift to the Dutch capital are coming to light. The building that will eventually host the agency will not be ready until the end of 2019 or even early 2020, according to two Dutch officials. The EMA has to move out of London by the end of March 2019, so it faces using one or more temporary buildingsin different parts of Amsterdam for its sensitive work on drug approvals until the new permanent premises are ready. An EMA official wrote that \u201ceach of the proposed temporary premises has weaknesses which raises concerns about EMA\u2019s continuity of operation even if this is only for a period limited in time,\u201d according to an internal email from November 28seen by POLITICO. \u201cWe know that it will not be smooth, they know,\u201d EMA Executive Director Guido Rasi said, pointing to Dutch officials at a meeting with all agency staff in London on November 24, according to a video recording of the meeting seen by POLITICO. \u201cWe already shared some common concerns, which means that we are realistic, we are not overpromising, but we are deeply committed to make it the best that can be done.\u201d Delivering on promises and expectations Amsterdam topped the preferences of EMA employees in a September survey, with 81 percent of them saying they would move to the Dutch city if the agency relocated there. \u201cAmsterdam ticks many of our boxes,\u201d Rasi said soon after the city was chosen to be the new host. \u201cIt offers excellent connectivity and a building that can be shaped according to our needs.\u201d Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018 The city has a major airport connecting it to the rest of the world and is just across the English Channel from London. The Dutch promised to ensure the agency could function seamlessly after its relocation. Amsterdam\u2019s proposed transition plan included individual support for each agency employee and doing whatever it took to get the building site ready. \u201cWe also have a very stylish queen and eat fish and chips,\u201d boasted the video presenting Amsterdam as the perfect new home for the EMA. The Netherlands made it clear when applying to host the EMA that the new offices wouldnot be ready by March 30, 2019, when the agency needs to move out of London because the U.K. ceases to be an EU member that day. It didn\u2019t specify when the agency\u2019s building would be fully ready, though, noting only that the offices would be made available throughout 2019. The European Medicines Agency building in Canary Wharf | Neil Hall\/EFE What it did promise was critical conference facilities would be ready by April 1, 2019, the first working day after Brexit. The EMA relies heavily on experts from across the EU coming together to assess new drug applications, which is why those fully equipped conference facilities are the agency\u2019s most urgent need. Amsterdam says those meeting rooms in the new building will be ready by April 1, 2019. But that leaves no time to address any issues that come along with new construction. And while the Dutch bid promises to deliver meeting spaces, it\u2019s not clear it will have the 4G internet connection, audio and video conference equipment, and a voting system per seat to satisfy EMA needs from Day One. And it will be a further seven or eight months before the time the rest of the building is completed and all EMA staff are in one place, said Udo Kock, Amsterdam\u2019s deputy mayor for finance and economic affairs. Temporary workspaces for some staff could \u201chave implications for the operational efficiencies during the transition period,\u201d said one assessment published in September which was commissioned by the pharma lobby EFPIA. It\u2019s not yet clear whether staffers would be split between multiple sites in Amsterdam. One proposed temporary office building is two metro stops away or a maximum 10-minute walk from the EMA\u2019s ultimate destination in Amsterdam, Maurice Galla, the project leader of the Dutch EMA candidacy, said at the EMA meeting. \u201cThe biggest hurdle is that by the time we have to move, our new building in Amsterdam will not be ready for us,\u201d Rasi told members of the European Parliament\u2019s environment and public health committee Thursday. \u201cWe are working with the Dutch authorities to find another solution \u2014 the temporary building will be crucial for our business continuity as of March 2019.\u201d Winning strategy becomes Achilles\u2019 heel Constructing a new building was supposed to be a strength of the city\u2019s bid, with the Dutch authorities wanting to give the EMA a fully customized new home similar to the one it has to leave in the Canary Wharf business district of London, Kock said. For others in the 16-way race to win the agency that had a ready-made space, including Italy and Denmark, Amsterdam\u2019s win may now seem especially bitter. The Italian and Danish cities competed head-to-head with the Netherlands in the three-round voting session on November 20. The agency needs a minimum 850 workspaces and 15 internal meeting rooms. Amsterdam won\u2019t even settle on a contractor for the EMA\u2019s new building until March 2018, Marcel van Raaij, a director in the Dutch health ministry, told EMA staffers at the November 24 meeting. And an internal EMA email sent late November 28, after the EMA staffers in charge of the relocation visited the premises in Amsterdam, raised concerns that the proposed temporary premises had weaknesses, \u201cespecially in terms of the amount of workspaces, of internal meeting rooms, of facilities as regards reprographics, local archiving.\u201d The agency needs a minimum 850 workspaces and 15 internal meeting rooms, with at least one of them able to host 30 people and the necessary space for reprographics and internal archives, preferably in only one building, the email said. \u201c..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909680.jpg","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909680.jpg","width":4961,"height":3311},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/after-amsterdam-high-eu-drugs-regulator-feels-the-pain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"After Amsterdam high, EU drugs regulator feels the pain"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics & Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/28397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=28397"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/28397\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/28398"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=28397"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=28397"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=28397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![](\"http:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53910400-714x432.jpg\"\/)
<\/p>\n![](\"http:\/\/www.bnreport.com\/wp-content\/uploads\/2017\/12\/h_53909028-714x476.jpg\"\/)
<\/p>\n